Relmada Therapeutics, Inc. · NASDAQ:RLMD

Squadron Capital Management LLC reported a 9.90% stake in Relmada Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 14, 2025

Squadron Capital Management LLC reported a 9.90% stake in Relmada Therapeutics, Inc., 3,298,500 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).

Stake
9.90%
Shares
3,298,500
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Squadron Master Fund LP8.80%2,914,495
Squadron Capital Management LLC9.90%3,298,500
William Blank9.90%3,298,500

Source

View original at SEC

Related